Unknown

Dataset Information

0

Aluminium adjuvants used in vaccines.

ABSTRACT: AbstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the benefits and harms of aluminium adjuvants used in a vaccine or an excipient versus the same vaccine or excipient, but having a different type of aluminium adjuvant formulation, or a different concentration, or with a different particle size.

SUBMITTER: Djurisic S 

PROVIDER: S-EPMC6373706 | biostudies-other | 2018 Jul

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Aluminium adjuvants used in vaccines versus placebo or no intervention.
| S-EPMC6483624 | biostudies-other
Unknown Identification of sheep lncRNAs related to the immune response to vaccines and aluminium adjuvants
| S-EPMC8554944 | biostudies-literature
Unknown Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps.
| S-EPMC8066953 | biostudies-literature
Unknown Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.
| S-EPMC4981857 | biostudies-other
Unknown Cancer Vaccines, Adjuvants, and Delivery Systems.
| S-EPMC8042385 | biostudies-literature
Unknown Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants.
| S-EPMC4586470 | biostudies-other
Unknown Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.
| S-EPMC5626599 | biostudies-literature
Unknown Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants.
| S-EPMC4804622 | biostudies-literature
Unknown Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants.
| S-EPMC7824815 | biostudies-literature
Unknown Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
| S-EPMC2265452 | biostudies-literature